Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
206.63   +1.83 (0.89%)  190.39 - 207.43  329,300

Overview

 
Avg Volume (4 weeks):192,470
4 Weeks Range:182.01 - 232.40
4 Weeks Price Volatility (%):
48.86%
52 Weeks Range:38.82 - 325.98
52 Weeks Price Volatility (%):
58.44%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

3245  4476  792  197 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HMNY 0.02+0.001 
 SPY 280.45+0.05 
 AMD 27.30-0.88 
 CZR 10.20+1.11 
 GE 12.19+0.09 
 XLF 27.02+0.27 
 BAC 28.90+0.37 
 EEM 40.36-0.50 
 VXX 32.47+0.49 
 QQQ 177.29+0.07 
Partners & Brokers